CLINICAL CHARACTERISTICS OF HOSPITALIZED COVID-19 PATIENTS WITH HEMODIALYSIS AT HO CHI MINH CITY UNIVERSITY MEDICAL CENTER
Main Article Content
Abstract
Objective: To describe clinical characteristics, laboratory data and early outcome of hospitalized COVID-19 patients with hemodialysis at the University Medical Center, Ho Chi Minh City. Method: We conducted a retrospective observational study from July 2021 to July 2022 to record data about patients with hemodialysis hospitalized due to COVID-19, diagnosed by RT-PCR. Descriptive statistics, chi-square test, logistic regression were performed in the statistical analysis. Results: Our study enrolled 56 patients with a mean age of 62.89 ± 2 years, with a female-to-male ratio of 1:1. The most frequently reported clinical symptoms were fever (60.7%), cough (66.3%), shortness of breath (50%). Among the 56 patients, 25 patients (44.6%) were classified as severe or critical degree, 8 patients (14.3%) died and 48 patients (85.7%) were able to be discharged within the observation period. The factors related to severity of COVID-19 include age over 60, diabetes, respiratory failure at presentation. Various laboratory parameters have been related with adverse outcomes. These encompass lymphopenia, elevated levels of LDH, interleukin-6, CRP, and procalcitonin. Moreover, we also find out protective factors including complete vaccination and good nutritional status of the patients. Conclusion: Our findings suggest that COVID-19 infection in hemodialysis patients increases the risk of mortality and poor prognosis. The risk of death and severity rises with age, comorbidities, respiratory failure, and elevated inflammatory markers at onset.
Article Details
Keywords
End-stage renal disease, hemodialysis, COVID-19, SARS-CoV-2
References
2. Đàm MK, Lê THV, Nguyễn TQM & Phan VB. Khảo sát tỉ lệ tử vong ở các bệnh nhân bệnh thận mạn nhiễm COVID-19 điều trị ngoại trú tại Khoa Nội Thận - Miễn dịch ghép Bệnh viện nhân dân 115. Tạp chí Y học Việt Nam 2023; 529 (1). https://doi.org/10.51298/vmj.v529i1.6268.
3. Alsayed AR, Ahmed SI, Al Shweiki AO, et al. The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies. Biomolecules and Biomedicine 2024, Vol 24, No 2: 238-255. Doi: 10.17305/bb.2023.9540.
4. Goicoecha M, Camara LAS, Macias N., et al. COVID-19: Clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int (2020) 98: 27-34. https://doi.org/10.1016/j.kint.2020.04.031.
5. Li P, Guan Y, Zhou S, et al. Mortality and risk factors for COVID-19 in hemodialysis patients: a systematic review and meta-analysis. Science progress 2022, Vol 105 (3): 1-21. Doi: 10.1177/00368504221110858.
6. Reis T, Fisher M, Nash C, et al. Chapter 59: Kidney Diseases associated with Coronavirus. In: Comprehensive Clinical Nephrology, Johnson RJ, Floege J, Tonelli M, eds, 7th edtion, Elsevier 2024.
7. Stefan G, Mehedinti AM, Andreiana I, et al. Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a teritiary nephrology care center in Romania. Renal Failure 2021, Vol 43, No 1: 49-57. https://doi.org/10.1080/0886022X.2020.1853571.
8. Zeng B, Zhou J, Peng D, et al. The prevention and treatment of COVID-19 in patients treated with hemodialysis. European Jpurnal of Medical Research (2023): 28: 410. https://doi.org/10.1186/s40001-023-01389-9.